Allergy and Immunology

Allergy and Immunology Publications

  1. Assa'ad A, Fiocchi A. Guidelines change the diagnostic process of cow milk food allergy: problem-based learning. Curr Opin Allergy Clin Immunol. 2012; 12:564-9.
  2. Bochner BS, Book W, Busse WW, Butterfield J, Furuta GT, Gleich GJ, Klion AD, Lee JJ, Leiferman KM, Minnicozzi M, Moqbel R, Rothenberg ME, Schwartz LB, Simon HU, Wechsler ME, Weller PF. Workshop report from the National Institutes of Health Taskforce on the Research Needs of Eosinophil-Associated Diseases (TREAD). J Allergy Clin Immunol. 2012; 130:587-96.
  3. Bochner BS, Rothenberg ME, Boyce JA, Finkelman F. Advances in mechanisms of allergy and clinical immunology in 2012. J Allergy Clin Immunol. 2013; 131:661-7.
  4. Collison A, Hatchwell L, Verrills N, Wark PA, de Siqueira AP, Tooze M, Carpenter H, Don AS, Morris JC, Zimmermann N, Bartlett NW, Rothenberg ME, Johnston SL, Foster PS, Mattes J. The E3 ubiquitin ligase midline 1 promotes allergen and rhinovirus-induced asthma by inhibiting protein phosphatase 2A activity. Nat Med. 2013; 19:232-7.
  5. Davis BP, Rothenberg ME. Emerging concepts of dietary therapy for pediatric and adult eosinophilic esophagitis. Expert Rev Clin Immunol. 2013; 9:285-7.
  6. Davis BP, Rothenberg ME. Antigen presentation by eosinophils in eosinophilic esophagitis?. J Pediatr Gastroenterol Nutr. 2013; 56:242.
  7. Davis BP, Rothenberg ME. Eosinophils and gastrointestinal disease. In: J Lee, HF Rosenberg, eds. Eosinophils in health and disease. Amsterdam; Boston, MA: Academic; 2012:404.
  8. Fiocchi A, Annunziato F, Assa'ad A, Arshad H, Bahna SL, Boyle R, Brozek J, Bush A, Canonica W, Cicardi M, Compalati E, Dahdah L, Dupont C, Finegold I, Fineman SM, Grabenhenrich L, Holgate S, Kuitunen M, Lau S, Maggi E, Martelli A, Matricardi P, Moretta L, Palmer D, Parronchi P, Pawankar R, Prescott S, Restani P, Rosenwasser L, Terracciano L, Scheurer S, Tripodi S, Vieths S, Von Berg A, Vultaggio A, Weber RW. The management of paediatric allergy: not everybody's cup of tea--10-11th February 2012. Curr Opin Allergy Clin Immunol. 2013; 13 Suppl 1:S1-50.
  9. Franciosi JP, Hommel KA, DeBrosse CW, Greenberg AB, Greenler AJ, Abonia JP, Rothenberg ME, Varni JW. Quality of life in paediatric eosinophilic oesophagitis: what is important to patients?. Child Care Health Dev. 2012; 38:477-83.
  10. Franciosi JP, Hommel KA, Greenberg AB, DeBrosse CW, Greenler AJ, Abonia JP, Rothenberg ME, Varni JW. Development of the Pediatric Quality of Life Inventory Eosinophilic Esophagitis module items: qualitative methods. BMC Gastroenterol. 2012; 12:135.
  11. Fukuda K, Kuo CH, Morohoshi K, Liu FT, Ono SJ. The murine CCR3 receptor regulates both eosinophilia and hyperresponsiveness in IgE-mediated allergic conjunctivitis. Br J Ophthalmol. 2012; 96:1132-6.
  12. Fulkerson PC, Rothenberg ME. Targeting eosinophils in allergy, inflammation and beyond. Nat Rev Drug Discov. 2013; 12:117-29.
  13. Groschwitz KR, Wu D, Osterfeld H, Ahrens R, Hogan SP. Chymase-mediated intestinal epithelial permeability is regulated by a protease-activating receptor/matrix metalloproteinase-2-dependent mechanism. Am J Physiol Gastrointest Liver Physiol. 2013; 304:G479-89.
  14. Henderson CJ, Collins MH, Abonia JP, Putnam PE, Rothenberg ME. Reply. J Allergy Clin Immunol. 2013; 131:243-4.
  15. Hogan SP. Neonatal Fc receptor (FcRn) and maternal-to-newborn IgE absorption. Clin Exp Allergy. 2012; 42:1656-9.
  16. Hogan SP, Waddell A, Fulkerson PC. Eosinophils in infection and intestinal immunity. Curr Opin Gastroenterol. 2013; 29:7-14.
  17. Hogan SP, Wang YH, Strait R, Finkelman FD. Food-induced anaphylaxis: mast cells as modulators of anaphylactic severity. Semin Immunopathol. 2012; 34:643-53.
  18. Hommel KA, Franciosi JP, Gray WN, Hente EA, Ahrens A, Rothenberg ME. Behavioral functioning and treatment adherence in pediatric eosinophilic gastrointestinal disorders. Pediatr Allergy Immunol. 2012; 23:494-9.
  19. Huggins J, Risma KA, Fine KS. Immunology, Allergy, and Rheumatology. In: BS Marino, KS Fine, eds. Blueprints Pediatrics. Baltimore, MD: Wolters Kluwer/Lippincott Williams & Wilkins; 2013:224-240.
  20. Kuo CH, Morohoshi K, Aye CC, Garoon RB, Collins A, Ono SJ. The role of TRB3 in mast cells sensitized with monomeric IgE. Exp Mol Pathol. 2012; 93:408-15.
  21. Lu TX, Lim EJ, Besse JA, Itskovich S, Plassard AJ, Fulkerson PC, Aronow BJ, Rothenberg ME. MiR-223 deficiency increases eosinophil progenitor proliferation. J Immunol. 2013; 190:1576-82.
  22. Lu TX, Lim EJ, Itskovich S, Besse JA, Plassard AJ, Mingler MK, Rothenberg JA, Fulkerson PC, Aronow BJ, Rothenberg ME. Targeted ablation of miR-21 decreases murine eosinophil progenitor cell growth. PLoS One. 2013; 8:e59397.
  23. Lu TX, Lim EJ, Wen T, Plassard AJ, Hogan SP, Martin LJ, Aronow BJ, Rothenberg ME. MiR-375 is downregulated in epithelial cells after IL-13 stimulation and regulates an IL-13-induced epithelial transcriptome. Mucosal Immunol. 2012; 5:388-96.
  24. Mao H, Kano G, Hudson SA, Brummet M, Zimmermann N, Zhu Z, Bochner BS. Mechanisms of Siglec-F-induced eosinophil apoptosis: a role for caspases but not for SHP-1, Src kinases, NADPH oxidase or reactive oxygen. PLoS One. 2013; 8:e6813.
  25. McBerry C, Egan CE, Rani R, Yang Y, Wu D, Boespflug N, Boon L, Butcher B, Mirpuri J, Hogan SP, Denkers EY, Aliberti J, Herbert DR. Trefoil factor 2 negatively regulates type 1 immunity against Toxoplasma gondii. J Immunol. 2012; 189:3078-84.
  26. Mellor-Heineke S, Villanueva J, Jordan MB, Marsh R, Zhang K, Bleesing JJ, Filipovich AH, Risma KA. Elevated Granzyme B in Cytotoxic Lymphocytes is a Signature of Immune Activation in Hemophagocytic Lymphohistiocytosis. Front Immunol. 2013; 4:72.
  27. Morohoshi K, Ohbayashi M, Patel N, Chong V, Bird AC, Ono SJ. Identification of anti-retinal antibodies in patients with age-related macular degeneration. Exp Mol Pathol. 2012; 93:193-9.
  28. Patmore DM, Welch S, Fulkerson PC, Wu J, Choi K, Eaves D, Kordich JJ, Collins MH, Cripe TP, Ratner N. In vivo regulation of TGF-beta by R-Ras2 revealed through loss of the RasGAP protein NF1. Cancer Res. 2012; 72:5317-27.
  29. Rothenberg ME, Aceves S, Bonis PA, Collins MH, Gonsalves N, Gupta SK, Hirano I, Liacouras CA, Putnam PE, Spergel JM, Straumann A, Wershil BK, Furuta GT. Working with the US Food and Drug Administration: progress and timelines in understanding and treating patients with eosinophilic esophagitis. J Allergy Clin Immunol. 2012; 130:617-9.
  30. Roufosse FE, Kahn JE, Gleich GJ, Schwartz LB, Singh AD, Rosenwasser LJ, Denburg JA, Ring J, Rothenberg ME, Sheikh J, Haig AE, Mallett SA, Templeton DN, Ortega HG, Klion AD. Long-term safety of mepolizumab for the treatment of hypereosinophilic syndromes. J Allergy Clin Immunol. 2013; 131:461-7 e1-5.
  31. Saban DR, Calder V, Kuo CH, Reyes NJ, Dartt DA, Ono SJ, Niederkorn JY. New twists to an old story: novel concepts in the pathogenesis of allergic eye disease. Curr Eye Res. 2013; 38:317-30.
  32. Sin HS, Barski A, Zhang F, Kartashov AV, Nussenzweig A, Chen J, Andreassen PR, Namekawa SH. RNF8 regulates active epigenetic modifications and escape gene activation from inactive sex chromosomes in post-meiotic spermatids. Genes Dev. 2012; 26:2737-48.
  33. Toda M, Kuo CH, Borman SK, Richardson RM, Inoko A, Inagaki M, Collins A, Schneider K, Ono SJ. Evidence that formation of vimentin mitogen-activated protein kinase (MAPK) complex mediates mast cell activation following FcεRI/CC chemokine receptor 1 cross-talk. J Biol Chem. 2012; 287:24516-24.
  34. Valent P, Klion AD, Rosenwasser LJ, Arock M, Bochner BS, Butterfield JH, Gotlib J, Haferlach T, Hellmann A, Horny HP, Leiferman KM, Metzgeroth G, Matsumoto K, Reiter A, Roufosse F, Rothenberg ME, Simon HU, Sotlar K, Vandenberghe P, Weller PF, Gleich GJ. ICON: Eosinophil Disorders. World Allergy Organ J. 2012; 5:174-181.
  35. Waddell A, Ahrens R, Tsai YT, Sherrill JD, Denson LA, Steinbrecher KA, Hogan SP. Intestinal CCL11 and eosinophilic inflammation is regulated by myeloid cell-specific RelA/p65 in mice. J Immunol. 2013; 190:4773-85.
  36. Waddell A, Hogan SP. Eosinophil-mediated events in mouse models of food allergy. In: J Lee, HF Rosenberg, eds. Eosinophils in health and disease. Amsterdam; Boston, MA: Academic; 2012:559.
  37. Wang YH, Hogan SP, Fulkerson PC, Abonia JP, Rothenberg ME. Expanding the paradigm of eosinophilic esophagitis: Mast cells and IL-9. J Allergy Clin Immunol. 2013; 131:1583-5.
  38. Wechsler ME, Fulkerson PC, Bochner BS, Gauvreau GM, Gleich GJ, Henkel T, Kolbeck R, Mathur SK, Ortega H, Patel J, Prussin C, Renzi P, Rothenberg ME, Roufosse F, Simon D, Simon HU, Wardlaw A, Weller PF, Klion AD. Novel targeted therapies for eosinophilic disorders. J Allergy Clin Immunol. 2012; 130:563-71.
  39. Wen T, Besse JA, Mingler MK, Fulkerson PC, Rothenberg ME. Eosinophil adoptive transfer system to directly evaluate pulmonary eosinophil trafficking in vivo. Proc Natl Acad Sci U S A. 2013; 110:6067-72.
  40. Winer KK, Rothenberg ME, Guimond J, Handwerger S, Boxer LA, Grave G, Devaskar SU, Castle VP. The Child Health Research Centers: twenty-one years of promoting the development of pediatrician scientists from 1990-2011. J Pediatr. 2012; 161:975-6.
  41. Wu YP, Franciosi JP, Rothenberg ME, Hommel KA. Behavioral feeding problems and parenting stress in eosinophilic gastrointestinal disorders in children. Pediatr Allergy Immunol. 2012; 23:730-5.
  42. Yamada Y, Cancelas JA, Rothenberg ME. Models of eosinophilic leukemia. In: J Lee, HF Rosenberg, eds. Eosinophils in health and disease. Amsterdam; Boston, MA: Academic; 2012:562.
  43. Zhu X, Mose E, Zimmermann N. Proton channel HVCN1 is required for effector functions of mouse eosinophils. BMC Immunol. 2013; 14:24.
  44. Zhu X, Zimmermann N. Eosinophil chemotaxis. In: J Lee, HF Rosenberg, eds. Eosinophils in health and disease. Amsterdam ; Boston, MA: Academic; 2012:121.